Tupper Colleen Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$2.18M

Insider Activity of Tupper Colleen

According to the SEC Form 4 filings, Tupper Colleen, being in a position of

  1. EVP & Chief Financial Officer at Collegium Pharmaceutical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30000 shares for $1.22M,
    over all time since 2022-10-04, has bought 0 shares, and sold 108177 shares for $3.39M.

Biography of Tupper Colleen

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,215,7531100

Comparison of Insiders on Amount of Buys and Sells

2025-11-06SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
30,000
0.1072%
$40.53$1.22M-13.65%
2025-03-21SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
6,396
0.0203%
$30.03$192,069+17.89%
2025-03-20SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
1,206
0.0038%
$30.00$36,181+18.31%
2025-03-14SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
977
0.0032%
$30.00$29,313+19.37%
2025-03-11SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
10,445
0.0332%
$30.01$313,413+17.24%
2025-03-07SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
1,504
0.005%
$30.00$45,121+20.81%
2025-03-06SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
1,949
0.0062%
$30.00$58,470+17.18%
2024-05-28SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
19,710
0.06%
$34.21$674,368-7.84%
2023-03-15SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
31,640
0.0947%
$23.77$752,165-0.59%
2022-10-04SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
4,350
0.0128%
$17.35$75,473+31.63%
Total: 10
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.